Literature DB >> 21909072

IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes.

Gaetana Restivo1, Bach-Cuc Nguyen, Piotr Dziunycz, Elodie Ristorcelli, Russell J H Ryan, Özden Yalçin Özuysal, Matteo Di Piazza, Freddy Radtke, Michael J Dixon, Günther F L Hofbauer, Karine Lefort, G Paolo Dotto.   

Abstract

While the pro-differentiation and tumour suppressive functions of Notch signalling in keratinocytes are well established, the underlying mechanisms remain poorly understood. We report here that interferon regulatory factor 6 (IRF6), an IRF family member with an essential role in epidermal development, is induced in differentiation through a Notch-dependent mechanism and is a primary Notch target in keratinocytes and keratinocyte-derived SCC cells. Increased IRF6 expression contributes to the impact of Notch activation on growth/differentiation-related genes, while it is not required for induction of 'canonical' Notch targets like p21(WAF1/Cip1), Hes1 and Hey1. Down-modulation of IRF6 counteracts differentiation of primary human keratinocytes in vitro and in vivo, promoting ras-induced tumour formation. The clinical relevance of these findings is illustrated by the strikingly opposite pattern of expression of Notch1 and IRF6 versus epidermal growth factor receptor in a cohort of clinical SCCs, as a function of their grade of differentiation. Thus, IRF6 is a primary Notch target in keratinocytes, which contributes to the role of this pathway in differentiation and tumour suppression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909072      PMCID: PMC3243593          DOI: 10.1038/emboj.2011.325

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

Review 1.  IRF family of transcription factors as regulators of host defense.

Authors:  T Taniguchi; K Ogasawara; A Takaoka; N Tanaka
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor.

Authors:  B Luo; J C Aster; R P Hasserjian; F Kuo; J Sklar
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1.

Authors:  K Ohishi; B Varnum-Finney; D Flowers; C Anasetti; D Myerson; I D Bernstein
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

4.  Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership.

Authors:  Caleb M Bailey; Zhila Khalkhali-Ellis; Shinji Kondo; Naira V Margaryan; Richard E B Seftor; William W Wheaton; Sumaira Amir; Michael R Pins; Brian C Schutte; Mary J C Hendrix
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

5.  Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression.

Authors:  P H Jones; F M Watt
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

6.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

Authors:  Maya Dajee; Mirella Lazarov; Jennifer Y Zhang; Ti Cai; Cheryl L Green; Alan J Russell; M Peter Marinkovich; Shiying Tao; Qun Lin; Yoshiaki Kubo; Paul A Khavari
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

7.  Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.

Authors:  Alexis Dumortier; André-Dante Durham; Matteo Di Piazza; Sophie Vauclair; Ute Koch; Gisèle Ferrand; Isabel Ferrero; Shadmehr Demehri; Lynda Li Song; Andrew G Farr; Warren J Leonard; Raphael Kopan; Lucio Miele; Daniel Hohl; Daniela Finke; Freddy Radtke
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

Review 8.  Notch tumor suppressor function.

Authors:  G P Dotto
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

9.  Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes.

Authors:  Shinji Kondo; Brian C Schutte; Rebecca J Richardson; Bryan C Bjork; Alexandra S Knight; Yoriko Watanabe; Emma Howard; Renata L L Ferreira de Lima; Sandra Daack-Hirsch; Achim Sander; Donna M McDonald-McGinn; Elaine H Zackai; Edward J Lammer; Arthur S Aylsworth; Holly H Ardinger; Andrew C Lidral; Barbara R Pober; Lina Moreno; Mauricio Arcos-Burgos; Consuelo Valencia; Claude Houdayer; Michel Bahuau; Danilo Moretti-Ferreira; Antonio Richieri-Costa; Michael J Dixon; Jeffrey C Murray
Journal:  Nat Genet       Date:  2002-09-03       Impact factor: 38.330

10.  Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch.

Authors:  Rebecca J Richardson; Jill Dixon; Saimon Malhotra; Matthew J Hardman; Lynnette Knowles; Ray P Boot-Handford; Paul Shore; Alan Whitmarsh; Michael J Dixon
Journal:  Nat Genet       Date:  2006-10-15       Impact factor: 38.330

View more
  64 in total

1.  Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.

Authors:  Bing Hu; Einar Castillo; Louise Harewood; Paola Ostano; Alexandre Reymond; Reinhard Dummer; Wassim Raffoul; Wolfram Hoetzenecker; Günther F L Hofbauer; G Paolo Dotto
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Genome-scale study of transcription factor expression in the branching mouse lung.

Authors:  John C Herriges; Lan Yi; Elizabeth A Hines; Julie F Harvey; Guoliang Xu; Paul A Gray; Qiufu Ma; Xin Sun
Journal:  Dev Dyn       Date:  2012-07-20       Impact factor: 3.780

Review 3.  The double-edged sword of Notch signaling in cancer.

Authors:  Andrew P South; Raymond J Cho; Jon C Aster
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

Review 4.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

5.  Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.

Authors:  Andrea Clocchiatti; Soumitra Ghosh; Maria-Giuseppina Procopio; Luigi Mazzeo; Pino Bordignon; Paola Ostano; Sandro Goruppi; Giulia Bottoni; Atul Katarkar; Mitchell Levesque; Peter Kölblinger; Reinhard Dummer; Victor Neel; Berna C Özdemir; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

Review 6.  Cutaneous Notch signaling in health and disease.

Authors:  Craig Nowell; Freddy Radtke
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 7.  Notch as a tumour suppressor.

Authors:  Craig S Nowell; Freddy Radtke
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

8.  Inhibition of Notch Signaling During Mouse Incisor Renewal Leads to Enamel Defects.

Authors:  Andrew H Jheon; Michaela Prochazkova; Bo Meng; Timothy Wen; Young-Jun Lim; Adrien Naveau; Ruben Espinoza; Timothy C Cox; Eli D Sone; Bernhard Ganss; Christian W Siebel; Ophir D Klein
Journal:  J Bone Miner Res       Date:  2015-08-06       Impact factor: 6.741

9.  Alcohol drinking inhibits NOTCH-PAX9 signaling in esophageal squamous epithelial cells.

Authors:  Menghan Shi; Shuang Ren; Hao Chen; Jing Li; Caizhi Huang; Yahui Li; Yuning Han; Yong Li; Zheng Sun; Xiaoxin Chen; Zhaohui Xiong
Journal:  J Pathol       Date:  2021-01-18       Impact factor: 7.996

Review 10.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.